Some of the most significant technology cycles begin in a relatively narrow corner of the market and...
The investment landscape surrounding psychedelic medicine bears little resemblance to the one that e...
Until recently, psychedelic medicine had plenty of scientific momentum but very little regulatory vi...
Market leadership rarely stays in one place for long.
More than $1 trillion in stock buybacks were announced by U.S. companies during the first half of 20...
For years, skeptics asked the same question about psychedelic medicine: "If this is real, where is B...
AdvisorShares Q Dynamic Growth ETF (QPX) has received a 5-star Morningstar Rating™ for its Overall, ...
12:00 pm ET | Monday – Friday Live, interactive video broadcast with industry leaders and experts di...
Summer is here, and with it comes the familiar hum of air conditioners running around the clock. Fro...
Forget Buybacks: "Float Shrink" Is the Real Metric to Track If you follow financial news, you’ve see...
An investment in the Funds is subject to risk, including the possible loss of principal amount invested. The risks associated with each Fund include the risks associated with the underlying ETFs, which can result in higher volatility, and are detailed in each Fund’s prospectus and on each Fund’s webpage.
.jpg)
.jpg)

.jpg)

.png)


.png)


